Nsynth Labs Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 28-06-2024
- Paid Up Capital ₹ 2.00 M
as on 28-06-2024
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 8.00 M
as on 28-06-2024
- Revenue 37.86%
(FY 2021)
- Profit -546.40%
(FY 2021)
- Ebitda 91.40%
(FY 2021)
- Net Worth -31.98%
(FY 2021)
- Total Assets -1.92%
(FY 2021)
About Nsynth Labs
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company has closed loans amounting to ₹8.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Malla Samala and Alivelu Samala serve as directors at the Company.
- CIN/LLPIN
U24301TG2013PTC085999
- Company No.
085999
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Mar 2013
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Nsynth Labs Private Limited offer?
Nsynth Labs Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Industrial Chemicals, Organic and Inorganic Solvents, Organic Chemicals, Pharma Ingredients & Raw Materials, API Intermediate, Chemical Intermediates.
Who are the key members and board of directors at Nsynth Labs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Malla Samala  | Director | 01-Mar-2013 | Current |
| Alivelu Samala | Director | 01-Mar-2013 | Current |
Financial Performance of Nsynth Labs.
Nsynth Labs Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 37.86% increase. The company also saw a substantial fall in profitability, with a 546.4% decrease in profit. The company's net worth observed a substantial decline by a decrease of 31.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nsynth Labs?
In 2019, Nsynth Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Onekem Pharma Private LimitedActive 9 years 4 monthsMalla Samala and Alivelu Samala are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Apr 2018 | ₹8.00 M | Satisfied |
How Many Employees Work at Nsynth Labs?
Unlock and access historical data on people associated with Nsynth Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nsynth Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nsynth Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
